Should Abbott and DexCom Investors Be Worried About Apple's Latest News?

Apple is reportedly developing a continuous glucose monitoring (CGM) device that doesn't require pricking the skin.
This news caused Abbott and DexCom stocks to fall last week, although both stocks have largely recovered since then.
Investors should be worried about Apple's threat, but there's a long way to go.